Additionally, the Kaplan–Meier survival and correlation analyses indicated that elevated SUCLG2 expression levels were significantly positively correlated with poor overall survival rates in patients with glioma (Fig. 1D, E). The gene discussed is SUCLG2; the disease is glioma.